BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Dong TS, Aby ES, Benhammou JN, Kawamoto J, Han SH, May FP, Pisegna JR. Metabolic syndrome does not affect sustained virologic response of direct-acting antivirals while hepatitis C clearance improves hemoglobin A1c. World J Hepatol 2018; 10(9): 612-621 [PMID: 30310539 DOI: 10.4254/wjh.v10.i9.612]
URL: https://www.wjgnet.com/1007-9327/full/v10/i9/612.htm
Number Citing Articles
1
Jihane N. Benhammou, Andrew M. Moon, Joseph R. Pisegna, Feng Su, Philip Vutien, Cynthia A. Moylan, George N. Ioannou. Nonalcoholic Fatty Liver Disease Risk Factors Affect Liver-Related Outcomes After Direct-Acting Antiviral Treatment for Hepatitis CDigestive Diseases and Sciences 2021; 66(7): 2394 doi: 10.1007/s10620-020-06457-2
2
Tiffany Khoo, Danielle Lam, John K Olynyk. Impact of modern antiviral therapy of chronic hepatitis B and C on clinical outcomes of liver diseaseWorld Journal of Gastroenterology 2021; 27(29): 4831-4845 doi: 10.3748/wjg.v27.i29.4831
3
Jyh‐Jou Chen, Pei‐Lun Lee, Hung‐Chih Chiu, Hung‐Da Tung, Yen‐Cheng Chiu, Pin‐Nan Cheng. Real‐world effectiveness and safety of ledipasvir/sofosbuvir for genotype 6 chronic hepatitis C patients in TaiwanJournal of Gastroenterology and Hepatology 2020; 35(3): 467 doi: 10.1111/jgh.14845
4
Man Yuan, Juan Zhou, Lingyao Du, Libo Yan, Hong Tang. Hepatitis C Virus Clearance with Glucose Improvement and Factors Affecting the Glucose Control in Chronic Hepatitis C PatientsScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-58786-x
5
Riccardo Nevola, Luca Rinaldi, Letizia Zeni, Ferdinando C Sasso, Pia C Pafundi, Barbara Guerrera, Aldo Marrone, Mauro Giordano, Luigi E Adinolfi. Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct‐acting antiviralsJGH Open 2020; 4(4): 713 doi: 10.1002/jgh3.12324
6
Tangui Barré, Marc Bourlière, Clémence Ramier, Fabrice Carrat, Vincent Di Beo, Camelia Protopopescu, Fabienne Marcellin, Morgane Bureau, Carole Cagnot, Céline Dorival, Fabien Zoulim, Jessica Zucman-Rossi, Jean-Charles Duclos-Vallée, Hélène Fontaine, Patrizia Carrieri. Cannabis Use Is Inversely Associated with Metabolic Disorders in Hepatitis C-Infected Patients (ANRS CO22 Hepather Cohort)Journal of Clinical Medicine 2022; 11(20): 6135 doi: 10.3390/jcm11206135
7
Ezequiel Ridruejo, Rebeca Garcia-Agudo, Manuel Mendizabal, Sami Aoufi-Rabih, Vivek Dixit, Marcelo Silva, Fabrizio Fabrizi. Efficacy and safety of direct-acting antiviral agents for HCV in mild-to-moderate chronic kidney diseaseNefrología 2020; 40(1): 46 doi: 10.1016/j.nefro.2019.03.013
8
Jizheng Chen, Pan Qiu, Tingfeng Zhao, Haowei Jiang, Kebinur Tursun, Sulaiman Ksimu, Xinwen Chen, Qian Wang. Measures of insulin resistance and beta cell function before and after treatment of HCV infectionVirologica Sinica 2024; 39(4): 667 doi: 10.1016/j.virs.2024.06.007
9
Chia‐Chi Wang, Pin‐Nan Cheng, Jia‐Horng Kao. Systematic review: chronic viral hepatitis and metabolic derangementAlimentary Pharmacology & Therapeutics 2020; 51(2): 216 doi: 10.1111/apt.15575
10
Hirokazu Takahashi, Takashi Nakahara, Tomomi Kogiso, Kento Imajo, Takaomi Kessoku, Takumi Kawaguchi, Tatsuya Ide, Miwa Kawanaka, Hideyuki Hyogo, Hideki Fujii, Masafumi Ono, Yoshihiro Kamada, Yoshio Sumida, Keizo Anzai, Masahito Shimizu, Takuji Torimura, Atsushi Nakajima, Katsutoshi Tokushige, Kazuaki Chayama, Yuichiro Eguchi. Eradication of hepatitis C virus with direct‐acting antivirals improves glycemic control in diabetes: A multicenter studyJGH Open 2021; 5(2): 228 doi: 10.1002/jgh3.12474
11
Elias Kouroumalis, Argyro Voumvouraki. Hepatitis C virus: A critical approach to who really needs treatmentWorld Journal of Hepatology 2022; 14(1): 1-44 doi: 10.4254/wjh.v14.i1.1
12
Ezequiel Ridruejo, Rebeca Garcia-Agudo, Manuel Mendizabal, Sami Aoufi-Rabih, Vivek Dixit, Marcelo Silva, Fabrizio Fabrizi. Efficacy and safety of direct-acting antiviral agents for HCV in mild-to-moderate chronic kidney diseaseNefrología (English Edition) 2020; 40(1): 46 doi: 10.1016/j.nefroe.2019.03.014
13
Lohanna STRAUHS-NITSCH, Marcela Ferro CAMPIOLO, Daphne Benatti Gonçalves MORSOLETTO, Alcindo PISSAIA JUNIOR, Claudia Alexandre Pontes IVANTES. CURING HEPATITIS C WITH THE NEW DIRECT ACTING ANTIVIRALS DID NOT IMPROVE INSULIN RESISTANCE AFTER ONE YEARArquivos de Gastroenterologia 2020; 57(3): 267 doi: 10.1590/s0004-2803.202000000-50